Antivenin (Micrurus fulvius)
Antivenin (Micrurus fulvius) is an FDA-licensed reference biologic from Wyeth Pharmaceuticals LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1967
Reference approved
Reference product
Not listed Antivenin (Micrurus fulvius)
Wyeth Pharmaceuticals LLC
- Approved
- Aug 28, 1967
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Antivenin (Micrurus fulvius), in chronological order.
Reference approval
Approval date of the reference Antivenin (Micrurus fulvius) product.
59 yr 7 mo ago
Frequently asked questions
Are there biosimilars approved for Antivenin (Micrurus fulvius)?
No 351(k) biosimilars or interchangeable biosimilars referencing Antivenin (Micrurus fulvius) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.